Dow rises as corporate earnings exceed expectations
19 Jul 2023 - The Dow Jones Industrial Average closed higher overnight as traders digested better-than-expected corporate earnings.
19Jul
18Jul
Are there ways to combat inflation other than by raising interest rates?
18 Jul 2023 - Dr Shane Oliver, Chief Economist at AMP, discusses the impact of interest rates and alternatives for fighting inflation.
18Jul
Stocks of the Hour: ABx Group, Lumos Diagnostics, OD6 Metals
18 Jul 2023 - A snapshot of the stocks on the move, featuring ABx Group (ASX:ABX), Lumos Diagnostics (ASX:LDX) and OD6 Metals (ASX:OD6).
18Jul
Stocks brace for earnings reports from global giants this week
18 Jul 2023 - Stocks were higher Monday as Wall Street braced for quarterly reports from some of the biggest companies in the world.
17Jul
Stocks of the Hour: Calmer Co Intl, DroneShield, Sovereign Metals
17 Jul 2023 - A snapshot of the stocks on the move, featuring Calmer Co. International (ASX:CCO), DroneShield (ASX:DRO) and Sovereign Metals (ASX:SVM).
17Jul
Market update with Shaw and Partners, July 2023
14 July 2023 - Shaw and Partners Chief Investment Officer Martin Crabb takes a look at the current economic situation and what it means for portfolios and investments going forward.
17Jul
Dow Jones surges on strong earnings kickoff
17 Jul 2023 - The Dow Jones Industrial Average climbed Friday as strong earnings results from some of the biggest banks and companies kicked off earnings season.
14Jul
Stocks of the Hour: Neuren Pharmaceuticals, Green Technology Metals, One Click Group
14 Jul 2023 - A snapshot of the stocks on the move, featuring Neuren Pharmaceuticals (ASX:NEU), Green Technology Metals (ASX:GT1) and One Click Group (ASX:1CG).
14Jul
Stocks extend gains on better-than-expected PPI data
14 Jul 2023 - Stocks rose Thursday after June’s producer price index report rose less than anticipated, building upon optimism from Wednesday’s consumer price index data. The PPI rose 0.1 per cent in June.
13Jul
Dragonfly Biosciences discusses plans to list on ASX
12 Jul 2023 - Regan Saveall, CEO of leading UK CBD company Dragonfly Biosciences, discusses the company and its plans to list on the ASX in August.